Edoxaban clears approval hurdle on its way to first market
This article was originally published in Scrip
Executive Summary
Japan's ministry of health, labour and welfare has granted the first formal regulatory clearance worldwide for Daiichi Sankyo's novel anticoagulant Lixiana (edoxaban), although not in its main indication.